188 related articles for article (PubMed ID: 21745563)
1. Potency of inhibition of human DNA topoisomerase I by flavones assessed through physicochemical parameters.
Bensasson RV; Zoete V; Jossang A; Bodo B; Arimondo PB; Land EJ
Free Radic Biol Med; 2011 Oct; 51(7):1406-10. PubMed ID: 21745563
[TBL] [Abstract][Full Text] [Related]
2. Modelling topoisomerase I inhibition by minor groove binders.
Winkler D
Bioorg Med Chem; 2011 Feb; 19(4):1450-7. PubMed ID: 21273082
[TBL] [Abstract][Full Text] [Related]
3. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells.
López-Lázaro M; Willmore E; Austin CA
Mutat Res; 2010 Feb; 696(1):41-7. PubMed ID: 20025993
[TBL] [Abstract][Full Text] [Related]
4. Structure and properties of camptothecin derivatives, their protonated forms, and model interaction with the topoisomerase I-DNA complex.
Ivanova B; Spiteller M
Biopolymers; 2012 Feb; 97(2):134-44. PubMed ID: 21898362
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, topoisomerase-targeting activity and growth inhibition of lycobetaine analogs.
Baechler SA; Fehr M; Habermeyer M; Hofmann A; Merz KH; Fiebig HH; Marko D; Eisenbrand G
Bioorg Med Chem; 2013 Feb; 21(3):814-23. PubMed ID: 23266176
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
Singh M; Tandon V
Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of topopyrones.
Zaleski PA; Maini R; Leiris SJ; Elban MA; Hecht SM
J Nat Prod; 2012 Apr; 75(4):577-85. PubMed ID: 22462811
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids from the aerial parts of Macrothelypteris torresiana.
Fang W; Ruan J; Cai Y; Wei A; Zhou D; Zhang W
Nat Prod Res; 2011 Jan; 25(1):36-9. PubMed ID: 21240759
[TBL] [Abstract][Full Text] [Related]
9. 2',5,7-Trihydroxy-4',5'-(2,2-dimethylchromeno)-8-(3-hydroxy-3-methylbutyl) flavanone purified from Cudrania tricuspidata induces apoptotic cell death of human leukemia U937 cells.
Rho YH; Yoon SH; Kim EK; Kang JY; Lee BW; Park KH; Bae YS
Nat Prod Res; 2007 Jun; 21(7):616-24. PubMed ID: 17613819
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase I inactivation by a novel thiol reactive naphthoquinone.
Kennedy S; Dicesare JC; Sheaff RJ
Biochem Biophys Res Commun; 2011 Jun; 410(1):152-8. PubMed ID: 21651895
[TBL] [Abstract][Full Text] [Related]
11. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Thapa U; Thapa P; Karki R; Yun M; Choi JH; Jahng Y; Lee E; Jeon KH; Na Y; Ha EM; Cho WJ; Kwon Y; Lee ES
Eur J Med Chem; 2011 Aug; 46(8):3201-9. PubMed ID: 21601964
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerases I and II and cytotoxicity of compounds from Ulmus davidiana var. japonica.
Zheng MS; Lee YK; Li Y; Hwangbo K; Lee CS; Kim JR; Lee SK; Chang HW; Son JK
Arch Pharm Res; 2010 Sep; 33(9):1307-15. PubMed ID: 20945128
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle.
Castelli S; Vassallo O; Katkar P; Che CM; Sun RW; Desideri A
Arch Biochem Biophys; 2011 Dec; 516(2):108-12. PubMed ID: 22033340
[TBL] [Abstract][Full Text] [Related]
15. TCM active ingredient oxoglaucine metal complexes: crystal structure, cytotoxicity, and interaction with DNA.
Chen ZF; Shi YF; Liu YC; Hong X; Geng B; Peng Y; Liang H
Inorg Chem; 2012 Feb; 51(4):1998-2009. PubMed ID: 22309171
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human topoisomerase I and activation of caspase-3 by aza-angucyclinones and arylaminopyrimido[4,5-c]isoquinoline-7,10-quinones.
Monsalve FA; Valderrama JA; Vásquez D; Ibacache A; Rodríguez JA; González DR; Leiva E; González E
Int J Mol Med; 2012 Jul; 30(1):151-6. PubMed ID: 22485249
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase as target for antibacterial and anticancer drug discovery.
Kathiravan MK; Khilare MM; Nikoomanesh K; Chothe AS; Jain KS
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):419-35. PubMed ID: 22380774
[TBL] [Abstract][Full Text] [Related]
18. From Lead to Drug Utilizing a Mannich Reaction: The Topotecan Story.
Bracher F; Tremmel T
Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 27805723
[TBL] [Abstract][Full Text] [Related]
19. Role of flexibility and long range communication on the function of human topoisomerase I.
Chillemi G; Fiorani P; Bruselles A; Castelli S; Campagna A; Sarra O; Tesauro C; Fiorentini M; Vassallo O; D'Annessa I; Santoleri S; Desideri A
Ital J Biochem; 2007 Jun; 56(2):110-4. PubMed ID: 17722651
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system.
Kennedy S; DiCesare JC; Sheaff RJ
Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
